Cytosorbents
CTSO
#10610
Rank
HK$0.18 B
Marketcap
HK$2.89
Share price
2.00%
Change (1 day)
-59.59%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2026 (TTM): -HK$95.48 Million

According to Cytosorbents's latest financial reports the company's current earnings are HK$37.2 Million. In 2025 the company made an earning of -HK$67.44 Million, an increase over its 2024 earnings that were of -HK$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$95.48 Million41.58%
2025 -HK$67.44 Million-62.16%
2024 -HK$0.18 Billion-22.49%
2023 -HK$0.23 Billion-13.52%
2022 -HK$0.27 Billion34.04%
2021 -HK$0.2 Billion182.17%
2020 -HK$70.3 Million-55.97%
2019 -HK$0.16 Billion14.17%
2018 -HK$0.14 Billion95.14%
2017 -HK$71.66 Million-22.32%
2016 -HK$92.25 Million39.1%
2015 -HK$66.32 Million-12.89%
2014 -HK$76.13 Million89%
2013 -HK$40.28 Million26.65%
2012 -HK$31.81 Million-26.02%
2011 -HK$42.99 Million-288.45%
2010 HK$22.81 M-4.17%
2009 HK$23.8 M-287.19%
2008 -HK$12.72 Million-47.12%
2007 -HK$24.05 Million41.78%
2006 -HK$16.97 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
HK$29.34 B-30,646.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
HK$6.09 B-6,447.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO
HK$0.43 B-553.11%๐Ÿ‡บ๐Ÿ‡ธ USA